By Anthony O. Goriainoff
Hikma Pharmaceuticals PLC said Wednesday that Riad Mishlawi has been appointed chief executive officer effective Sept. 1 and that Said Darwazah will step down as acting CEO and return to his role as executive chairman.
The London-listed company said Mr. Mishlawi–currently president of the company’s injectables business-will…
Read the full article here